- Report
- November 2024
- 110 Pages
Global
From €5223EUR$5,950USD£4,544GBP
- Report
- January 2024
- 113 Pages
United States
€3072EUR$3,500USD£2,673GBP
Neoral is a brand of cyclosporine, an immunosuppressant drug used to treat psoriasis. It is a calcineurin inhibitor, meaning it works by blocking the action of a certain enzyme that is involved in the body's inflammatory response. Neoral is available in both oral and topical forms, and is often used in combination with other psoriasis treatments. It is generally well-tolerated, but can cause side effects such as nausea, vomiting, and headaches.
Neoral is one of several psoriasis drugs on the market, and is often prescribed as a first-line treatment for moderate to severe psoriasis. It is also used to treat other autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
Some companies in the Neoral market include Novartis, Sandoz, and Mylan. Show Less Read more